These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 24795078)

  • 1. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
    Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
    J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of halobetasol propionate and its impurities present in topical dosage forms by stability-indicating LC method.
    Nalwade S; Reddy VR; Kulkarni D; Todamal S
    J Chromatogr Sci; 2015 Jan; 53(1):127-34. PubMed ID: 24784115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
    Sharma N; Rao SS; Reddy AM
    J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
    Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
    J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-indicating UPLC method for determining related substances and degradants in dronedarone.
    Pydimarry SP; Cholleti VK; Vangala RR
    J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability indicating LC method for rapid determination of related substances of O-desmethyl venlafaxine in active pharmaceutical ingredients and pharmaceutical formulations.
    Rao KV; Reddy KP; Kumar YR
    J Chromatogr Sci; 2014; 52(10):1247-54. PubMed ID: 24474426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
    Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
    J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced degradation studies of clobetasol 17-propionate in methanol, propylene glycol, as bulk drug and cream formulations by RP-HPLC.
    Fauzee AF; Walker RB
    J Sep Sci; 2013 Mar; 36(5):849-56. PubMed ID: 23355423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
    Shaik JV; Saladi S; Sait SS
    J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated stability-indicating UPLC method for the determination of impurities in Maraviroc.
    Chilukuri M; Hussainreddy K; Narayanareddy P; Venkataramana M
    J Chromatogr Sci; 2014 Aug; 52(7):609-16. PubMed ID: 23825352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stability-indicating ultra-performance liquid chromatographic method for estimation of related substances and degradants in paliperidone active pharmaceutical ingredient and its pharmaceutical dosage forms.
    Bindu KH; Reddy IU; Anjaneyulu Y; Suryanarayana MV
    J Chromatogr Sci; 2012 Apr; 50(4):368-72. PubMed ID: 22407348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design approach for the separation of naproxcinod and its related substances by fused core particle technology column.
    Inugala UR; Pothuraju NR; Vangala RR
    J Chromatogr Sci; 2013; 51(5):453-9. PubMed ID: 23060406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stability-indicating HPLC method for the determination of bazedoxifene acetate and its related substances in active pharmaceutical ingredient.
    Visweswara Rao K; Reddy KP; Kumari KS; Srinivas M
    J Chromatogr Sci; 2013 Mar; 51(3):215-21. PubMed ID: 22865837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation.
    Prakash L; Himaja M; Vasudev R
    Sci Pharm; 2015; 83(1):65-83. PubMed ID: 26839802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.